Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.

scientific article published in June 2019

Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S1474-4422(19)30147-4
P932PMC publication ID6527868
P698PubMed publication ID31122493

P50authorEirini-Christina SalonikiQ56423390
Catherine M SackleyQ56885782
P2093author name stringAmanda J Farrin
David Meads
Suzanne Hartley
John Pearn
Gary A Ford
Gillian Santorelli
Ivana Holloway
Marion F Walker
Sharon Ruddock
Bipin B Bhakta
Alastair Cozens
P2860cites workFUNCTIONAL EVALUATION: THE BARTHEL INDEXQ28201591
Dopamine in motor cortex is necessary for skill learning and synaptic plasticityQ30873734
The DARS (Dopamine Augmented Rehabilitation in Stroke) trial: protocol for a randomised controlled trial of Co-careldopa treatment in addition to routine NHS occupational and physical therapy after strokeQ34067590
Interobserver agreement for the assessment of handicap in stroke patients.Q34176187
Levodopa and the progression of Parkinson's diseaseQ34553278
Seven problems on the basal gangliaQ34903682
Speeding stroke recovery? A systematic review of amphetamine after strokeQ34982137
Effects of augmented exercise therapy time after stroke: a meta-analysisQ35912201
The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic reviewQ37662185
Levodopa improves procedural motor learning in chronic stroke patientsQ38387537
Biomarkers of stroke recovery: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable.Q38659060
Effect of methylphenidate and/or levodopa coupled with physiotherapy on functional and motor recovery after stroke--a randomized, double-blind, placebo-controlled trial.Q39861267
Neurochemical specificity of learning: dopamine and motor learning.Q41249296
Competition between feedback loops underlies normal and pathological dynamics in the basal ganglia.Q42492736
Long-term levodopa administration in chronic stroke patients. A clinical and neurophysiologic single-blind placebo-controlled cross-over pilot studyQ43279475
Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind studyQ43743049
Randomized, placebo-controlled, double-blind study of ropinirole in chronic strokeQ45274960
Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based studyQ48243342
The ABILHAND questionnaire as a measure of manual ability in chronic stroke patients: Rasch-based validation and relationship to upper limb impairment.Q48820888
The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment.Q52863130
Caregiver's burden of patients 3 years after stroke assessed by a novel caregiver burden scale.Q53628566
Psychometric qualities of a brief self-rated fatigue measure: The Fatigue Assessment ScaleQ73204607
Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized studyQ79420196
No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot studyQ80860624
P433issue6
P921main subjectplaceboQ269829
levodopa/carbidopaQ5037862
P304page(s)530-538
P577publication date2019-06-01
P1433published inLancet NeurologyQ15755067
P1476titleSafety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.
P478volume18

Reverse relations

cites work (P2860)
Q89467760Advances and challenges in stroke rehabilitation
Q92250788Dopamine for motor recovery after stroke: where to from here?